T. Chun, L. Carruth, D. Finzi, X. Shen, J. Digiuseppe et al., Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection, Nature, vol.387, issue.6629, pp.183-188, 1997.
DOI : 10.1038/387183a0

T. Chun, D. Finzi, J. Margolick, K. Chadwick, D. Schwartz et al., In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency, Nature Medicine, vol.4, issue.12, pp.1284-1290, 1995.
DOI : 10.1038/373117a0

A. Perelson, P. Essunger, Y. Cao, M. Vesanen, A. Hurley et al., Decay characteristics of HIV-1-infected compartments during combination therapy, Nature, vol.387, issue.6629, pp.188-191, 1997.
DOI : 10.1038/387188a0

J. Wong, M. Hezareh, H. Gunthard, D. Havlir, C. Ignacio et al., Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia, Science, vol.278, issue.5341, pp.1291-1295, 1997.
DOI : 10.1126/science.278.5341.1291

T. Chun, R. Davey, . Jr, M. Ostrowski, S. Justement et al., Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy, Nature Medicine, vol.6, issue.7, pp.757-761, 2000.
DOI : 10.1038/77481

D. Ho and L. Zhang, HIV-1 rebound after anti-retroviral therapy, Nature Medicine, vol.6, issue.7, pp.736-737, 2000.
DOI : 10.1038/77447

M. Dybul, M. Daucher, M. Jensen, C. Hallahan, T. Chun et al., Genetic Characterization of Rebounding Human Immunodeficiency Virus Type 1 in Plasma during Multiple Interruptions of Highly Active Antiretroviral Therapy, Journal of Virology, vol.77, issue.5, pp.3229-3237, 2003.
DOI : 10.1128/JVI.77.5.3229-3237.2003

J. Bailey, A. Sedaghat, T. Kieffer, T. Brennan, P. Lee et al., Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4+ T Cells, Journal of Virology, vol.80, issue.13, pp.6441-6457, 2006.
DOI : 10.1128/JVI.00591-06

B. Keele, L. Tazi, S. Gartner, Y. Liu, T. Burgon et al., Characterization of the Follicular Dendritic Cell Reservoir of Human Immunodeficiency Virus Type 1, Journal of Virology, vol.82, issue.11, pp.5548-5561, 2008.
DOI : 10.1128/JVI.00124-08

T. Zhu, D. Muthui, S. Holte, D. Nickle, F. Feng et al., Evidence for Human Immunodeficiency Virus Type 1 Replication In Vivo in CD14+ Monocytes and Its Potential Role as a Source of Virus in Patients on Highly Active Antiretroviral Therapy, Journal of Virology, vol.76, issue.2, pp.707-716, 2002.
DOI : 10.1128/JVI.76.2.707-716.2002

A. Alexaki, Y. Liu, and B. Wigdahl, Cellular Reservoirs of HIV-1 and their Role in Viral Persistence, Current HIV Research, vol.6, issue.5, pp.388-400, 2008.
DOI : 10.2174/157016208785861195

A. Alexaki and B. Wigdahl, HIV-1 Infection of Bone Marrow Hematopoietic Progenitor Cells and Their Role in Trafficking and Viral Dissemination, PLoS Pathogens, vol.27, issue.1, p.1000215, 2008.
DOI : 10.1371/journal.ppat.1000215.g003

C. Coleman and L. Wu, HIV interactions with monocytes and dendritic cells: viral latency and reservoirs, Retrovirology, vol.6, issue.1, p.51, 2009.
DOI : 10.1186/1742-4690-6-51

S. Crowe, T. Zhu, and W. Muller, The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection, Journal of Leukocyte Biology, vol.74, issue.5, pp.635-641, 2003.
DOI : 10.1189/jlb.0503204

L. Shen and R. Siliciano, Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection, Journal of Allergy and Clinical Immunology, vol.122, issue.1, pp.22-28, 2008.
DOI : 10.1016/j.jaci.2008.05.033

D. Ho, T. Rota, and M. Hirsch, Infection of monocyte/macrophages by human T lymphotropic virus type III., Journal of Clinical Investigation, vol.77, issue.5, pp.1712-1715, 1986.
DOI : 10.1172/JCI112491

J. Nicholson, G. Cross, C. Callaway, and J. Mcdougal, In vitro infection of human monocytes with human T lymphotropic virus type III/ lymphadenopathy-associated virus (HTLV-III/LAV), J Immunol, vol.137, pp.323-329, 1986.

A. Pelchen-matthews, B. Kramer, and M. Marsh, Infectious HIV-1 assembles in late endosomes in primary macrophages, The Journal of Cell Biology, vol.2, issue.3, pp.443-455, 2003.
DOI : 10.1128/JVI.75.6.2982-2992.2001

G. Raposo, M. Moore, D. Innes, R. Leijendekker, A. Leigh-brown et al., Human Macrophages Accumulate HIV-1 Particles in MHC II Compartments, Traffic, vol.3, issue.10, pp.718-729, 2002.
DOI : 10.1034/j.1600-0854.2002.31004.x

P. Bieniasz, The Cell Biology of HIV-1 Virion Genesis, Cell Host & Microbe, vol.5, issue.6, pp.550-558, 2009.
DOI : 10.1016/j.chom.2009.05.015

K. Williams, S. Corey, S. Westmoreland, D. Pauley, H. Knight et al., Perivascular Macrophages Are the Primary Cell Type Productively Infected by Simian Immunodeficiency Virus in the Brains of Macaques, The Journal of Experimental Medicine, vol.150, issue.8, pp.905-915, 2001.
DOI : 10.1126/science.2148832

O. Lambotte, Y. Taoufik, M. De-goer, C. Wallon, C. Goujard et al., Detection of Infectious HIV in Circulating Monocytes From Patients on Prolonged Highly Active Antiretroviral Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.23, issue.2, pp.114-119, 2000.
DOI : 10.1097/00126334-200002010-00002

M. Mcelrath, R. Steinman, and Z. Cohn, Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients., Journal of Clinical Investigation, vol.87, issue.1, pp.27-30, 1991.
DOI : 10.1172/JCI114981

P. Ellery, E. Tippett, Y. Chiu, G. Paukovics, P. Cameron et al., The CD16+ Monocyte Subset Is More Permissive to Infection and Preferentially Harbors HIV-1 In Vivo, The Journal of Immunology, vol.178, issue.10, pp.6581-6589, 2007.
DOI : 10.4049/jimmunol.178.10.6581

S. Aquaro, R. Calio, J. Balzarini, M. Bellocchi, E. Garaci et al., Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir, Antiviral Research, vol.55, issue.2, pp.209-225, 2002.
DOI : 10.1016/S0166-3542(02)00052-9

URL : http://www.sciencedirect.com/science?_ob=ShoppingCartURL&_method=add&_eid=1-s2.0-S0166354202000529&originContentFamily=serial&_origin=article&_ts=1480563639&md5=b87e5a8b5a33f7f560308ec361c32274

C. Perno, V. Svicher, and F. Ceccherini-silberstein, Novel drug resistance mutations in HIV: recognition and clinical relevance, AIDS Rev, vol.8, pp.179-190, 2006.

R. Veazey, M. Demaria, L. Chalifoux, D. Shvetz, D. Pauley et al., Gastrointestinal Tract as a Major Site of CD4+ T Cell Depletion and Viral Replication in SIV Infection, Science, vol.280, issue.5362, pp.427-431, 1998.
DOI : 10.1126/science.280.5362.427

P. Smith, G. Meng, J. Salazar-gonzalez, and G. Shaw, Macrophage HIV-1 infection and the gastrointestinal tract reservoir, Journal of Leukocyte Biology, vol.74, issue.5, pp.642-649, 2003.
DOI : 10.1189/jlb.0503219

T. Zhu, HIV-1 in peripheral blood monocytes: an underrated viral source, Journal of Antimicrobial Chemotherapy, vol.50, issue.3, pp.309-311, 2002.
DOI : 10.1093/jac/dkf143

A. Spira, P. Marx, B. Patterson, J. Mahoney, R. Koup et al., Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques, Journal of Experimental Medicine, vol.183, issue.1, pp.215-225, 1996.
DOI : 10.1084/jem.183.1.215

A. Smed-sorensen, K. Lore, J. Vasudevan, M. Louder, J. Andersson et al., Differential Susceptibility to Human Immunodeficiency Virus Type 1 Infection of Myeloid and Plasmacytoid Dendritic Cells, Journal of Virology, vol.79, issue.14, pp.8861-8869, 2005.
DOI : 10.1128/JVI.79.14.8861-8869.2005

K. Lore, A. Smed-sorensen, J. Vasudevan, J. Mascola, and R. Koup, T cells, The Journal of Experimental Medicine, vol.79, issue.12, pp.2023-2033, 2005.
DOI : 10.1182/blood-2003-07-2314

A. Haase, K. Henry, M. Zupancic, G. Sedgewick, R. Faust et al., Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue, Science, vol.274, issue.5289, pp.985-989, 1996.
DOI : 10.1126/science.274.5289.985

M. Otero, G. Nunnari, D. Leto, J. Sullivan, F. Wang et al., Peripheral Blood Dendritic Cells Are Not a Major Reservoir for HIV Type 1 in Infected Individuals on Virally Suppressive HAART, AIDS Research and Human Retroviruses, vol.19, issue.12, pp.1097-1103, 2003.
DOI : 10.1089/088922203771881194

C. Perno, V. Svicher, D. Schols, M. Pollicita, J. Balzarini et al., Therapeutic strategies towards HIV-1 infection in macrophages, Antiviral Research, vol.71, issue.2-3, pp.293-300, 2006.
DOI : 10.1016/j.antiviral.2006.05.015

R. Collman, N. Hassan, R. Walker, B. Godfrey, J. Cutilli et al., Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1)

J. Orenstein, C. Fox, and S. Wahl, Macrophages as a Source of HIV During Opportunistic Infections, Science, vol.276, issue.5320, pp.1857-1861, 1997.
DOI : 10.1126/science.276.5320.1857

E. Caselli, M. Galvan, E. Cassai, A. Caruso, L. Sighinolfi et al., Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells, Blood, vol.106, issue.8, pp.2790-2797, 2005.
DOI : 10.1182/blood-2005-04-1390

K. Williams and W. Hickey, AIDS, Annual Review of Neuroscience, vol.25, issue.1, pp.537-562, 2002.
DOI : 10.1146/annurev.neuro.25.112701.142822

URL : https://hal.archives-ouvertes.fr/hal-00590594

G. Garden, Microglia in human immunodeficiency virus-associated neurodegeneration, Glia, vol.22, issue.2, pp.240-251, 2002.
DOI : 10.1002/glia.10155

H. Lassmann, M. Schmied, K. Vass, and W. Hickey, Bone marrow derived elements and resident microglia in brain inflammation, Glia, vol.16, issue.1, pp.19-24, 1993.
DOI : 10.1002/glia.440070106

J. Carr, H. Ramshaw, P. Li, and C. Burrell, CD34+ cells and their derivatives contain mRNA for CD4 and human immunodeficiency virus (HIV)

M. Deichmann, R. Kronenwett, and R. Haas, Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD34+ hematopoietic progenitor cells, pp.3522-3528, 1997.

A. Aiuti, L. Turchetto, M. Cota, A. Cipponi, A. Brambilla et al., Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by Tcell tropic human immunodeficiency virus, Blood, vol.94, pp.62-73, 1999.

T. Folks, S. Kessler, J. Orenstein, J. Justement, E. Jaffe et al., Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow, Science, vol.242, issue.4880, pp.919-922, 1988.
DOI : 10.1126/science.2460922

K. Slobod, T. Bennett, P. Freiden, A. Kechli, N. Howlett et al., Mobilization of CD34+ progenitor cells by granulocyte colony-stimulating factor in human immunodeficiency virus type 1-infected adults, Blood, vol.88, pp.3329-3335, 1996.

S. Stanley, S. Kessler, J. Justement, S. Schnittman, J. Greenhouse et al., CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals, J Immunol, vol.149, pp.689-697, 1992.

P. Ancuta and L. Weiss, CD14+CD16++ cells derivedin vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics, European Journal of Immunology, vol.30, issue.7, pp.1872-1883, 2000.
DOI : 10.1002/1521-4141(200007)30:7<1872::AID-IMMU1872>3.0.CO;2-2

G. Randolph, S. Beaulieu, S. Lebecque, R. Steinman, and W. Muller, Differentiation of Monocytes into Dendritic Cells in a Model of Transendothelial Trafficking, Science, vol.282, issue.5388, pp.480-483, 1998.
DOI : 10.1126/science.282.5388.480

G. Randolph, K. Inaba, D. Robbiani, R. Steinman, and W. Muller, Differentiation of Phagocytic Monocytes into Lymph Node Dendritic Cells In Vivo, Immunity, vol.11, issue.6, pp.753-761, 1999.
DOI : 10.1016/S1074-7613(00)80149-1

J. Garcia, D. Harrich, E. Soultanakis, F. Wu, R. Mitsuyasu et al., Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation, Embo J, vol.8, pp.765-778, 1989.

S. Kingsman and A. Kingsman, The Regulation of Human Immunodeficiency Virus Type-1 Gene Expression, European Journal of Biochemistry, vol.266, issue.3, pp.491-507, 1996.
DOI : 10.1016/0092-8674(89)90416-9

L. Pereira, K. Bentley, A. Peeters, M. Churchill, and N. Deacon, SURVEY AND SUMMARY A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter, Nucleic Acids Research, vol.28, issue.3, pp.663-668, 2000.
DOI : 10.1093/nar/28.3.663

O. Rohr, C. Marban, D. Aunis, and E. Schaeffer, Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells, Journal of Leukocyte Biology, vol.74, issue.5, pp.736-749, 2003.
DOI : 10.1189/jlb.0403180

L. Redel, L. Douce, V. Cherrier, T. Marban, C. Janossy et al., HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes, Journal of Leukocyte Biology, vol.87, issue.4, pp.575-88, 2009.
DOI : 10.1189/jlb.0409264

M. Bukrinsky, N. Sharova, M. Dempsey, T. Stanwick, A. Bukrinskaya et al., Active nuclear import of human immunodeficiency virus type 1 preintegration complexes., Proceedings of the National Academy of Sciences, vol.89, issue.14, pp.6580-6584, 1992.
DOI : 10.1073/pnas.89.14.6580

Y. Chiu, V. Soros, J. Kreisberg, K. Stopak, W. Yonemoto et al., Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells, Nature, vol.70, issue.7038, pp.108-114, 2005.
DOI : 10.1038/nature02171

Y. Korin and J. Zack, Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes, J Virol, vol.73, pp.6526-6532, 1999.

J. Zack, A. Haislip, P. Krogstad, and I. Chen, Incompletely reversetranscribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle, J Virol, vol.66, pp.1717-1725, 1992.

L. Gillim-ross, C. A. Klotman, and M. , HIV-1 Extrachromosomal 2-LTR Circular DNA Is Long-Lived in Human Macrophages, Viral Immunology, vol.18, issue.1, pp.190-196, 2005.
DOI : 10.1089/vim.2005.18.190

S. Pang, Y. Koyanagi, S. Miles, C. Wiley, H. Vinters et al., High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients, Nature, vol.343, issue.6253, pp.85-89, 1990.
DOI : 10.1038/343085a0

D. Eckstein, M. Sherman, M. Penn, P. Chin, D. Noronha et al., T Cells, The Journal of Experimental Medicine, vol.63, issue.10, pp.1407-1419, 2001.
DOI : 10.1038/77481

B. Poon and I. Chen, Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Enhances Expression from Unintegrated HIV-1 DNA, Journal of Virology, vol.77, issue.7, pp.3962-3972, 2003.
DOI : 10.1128/JVI.77.7.3962-3972.2003

J. Kelly, M. Beddall, D. Yu, S. Iyer, J. Marsh et al., Human macrophages support persistent transcription from unintegrated HIV-1 DNA, Virology, vol.372, issue.2, pp.300-312, 2008.
DOI : 10.1016/j.virol.2007.11.007

A. Cara and M. Klotman, Retroviral E-DNA: persistence and gene expression in nondividing immune cells, Journal of Leukocyte Biology, vol.80, issue.5, pp.1013-1017, 2006.
DOI : 10.1189/jlb.0306151

K. Lassen, Y. Han, Y. Zhou, J. Siliciano, and R. Siliciano, The multifactorial nature of HIV-1 latency, Trends in Molecular Medicine, vol.10, issue.11, pp.525-531, 2004.
DOI : 10.1016/j.molmed.2004.09.006

A. Marcello, Latency: the hidden HIV-1 challenge, Retrovirology, vol.3, issue.1, p.7, 2006.
DOI : 10.1186/1742-4690-3-7

A. Jordan, P. Defechereux, and E. Verdin, The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation, The EMBO Journal, vol.20, issue.7, pp.1726-1738, 2001.
DOI : 10.1093/emboj/20.7.1726

Y. Han, Y. Lin, A. W. Xu, J. Yang, H. et al., Orientation-Dependent Regulation of Integrated HIV-1 Expression by Host Gene Transcriptional Readthrough, Cell Host & Microbe, vol.4, issue.2, pp.134-146, 2008.
DOI : 10.1016/j.chom.2008.06.008

T. Lenasi, X. Contreras, and B. Peterlin, Transcriptional Interference Antagonizes Proviral Gene Expression to Promote HIV Latency, Cell Host & Microbe, vol.4, issue.2, pp.123-133, 2008.
DOI : 10.1016/j.chom.2008.05.016

H. Mancebo, G. Lee, J. Flygare, J. Tomassini, P. Luu et al., P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in??vitro, Genes & Development, vol.11, issue.20, pp.2633-2644, 1997.
DOI : 10.1101/gad.11.20.2633

P. Wei, M. Garber, S. Fang, W. Fischer, and K. Jones, A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA, Cell, vol.92, issue.4, pp.451-462, 1998.
DOI : 10.1016/S0092-8674(00)80939-3

Y. Zhu, T. Pe-'ery, J. Peng, Y. Ramanathan, N. Marshall et al., Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in??vitro, Genes & Development, vol.11, issue.20, pp.2622-2632, 1997.
DOI : 10.1101/gad.11.20.2622

L. Liou, C. Herrmann, and A. Rice, HIV-1 infection and regulation of Tat function in macrophages, The International Journal of Biochemistry & Cell Biology, vol.36, issue.9, pp.1767-1775, 2004.
DOI : 10.1016/j.biocel.2004.02.018

C. Dong, C. Kwas, and L. Wu, Transcriptional Restriction of Human Immunodeficiency Virus Type 1 Gene Expression in Undifferentiated Primary Monocytes, Journal of Virology, vol.83, issue.8, pp.3518-3527, 2009.
DOI : 10.1128/JVI.02665-08

A. Henderson and K. Calame, CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4+ T cells, Proceedings of the National Academy of Sciences, vol.94, issue.16, pp.8714-8719, 1997.
DOI : 10.1073/pnas.94.16.8714

A. Henderson, R. Connor, and K. Calame, C/EBP Activators Are Required for HIV-1 Replication and Proviral Induction in Monocytic Cell Lines, Immunity, vol.5, issue.1, pp.91-101, 1996.
DOI : 10.1016/S1074-7613(00)80313-1

V. Tesmer and M. Bina, Regulation of HIV-1 Gene Expression by NF-IL6, Journal of Molecular Biology, vol.262, issue.3, pp.327-335, 1996.
DOI : 10.1006/jmbi.1996.0516

C. Schwartz, P. Catez, O. Rohr, D. Lecestre, D. Aunis et al., Functional Interactions between C/EBP, Sp1, and COUP-TF Regulate Human Immunodeficiency Virus Type 1 Gene Transcription in Human Brain Cells, Journal of Virology, vol.74, issue.1, pp.65-73, 2000.
DOI : 10.1128/JVI.74.1.65-73.2000

M. Weiden, N. Tanaka, Y. Qiao, B. Zhao, Y. Honda et al., Differentiation of Monocytes to Macrophages Switches the Mycobacterium tuberculosis Effect on HIV-1 Replication from Stimulation to Inhibition: Modulation of Interferon Response and CCAAT/Enhancer Binding Protein ?? Expression, The Journal of Immunology, vol.165, issue.4, pp.2028-2039, 2000.
DOI : 10.4049/jimmunol.165.4.2028

S. Barber, L. Gama, J. Dudaronek, T. Voelker, P. Tarwater et al., Mechanism for the Establishment of Transcriptional HIV Latency in the Brain in a Simian Immunodeficiency Virus???Macaque Model, The Journal of Infectious Diseases, vol.193, issue.7, pp.963-970, 2006.
DOI : 10.1086/500983

R. Horie, T. Ishida, M. Maruyama-nagai, K. Ito, M. Watanabe et al., TRAF activation of C/EBP?? (NF-IL6) via p38 MAPK induces HIV-1 gene expression in monocytes/macrophages???, Microbes and Infection, vol.9, issue.6, pp.721-728, 2007.
DOI : 10.1016/j.micinf.2007.02.017

K. Carlson, G. Leisman, J. Limoges, G. Pohlman, M. Horiba et al., Molecular Characterization of a Putative Antiretroviral Transcriptional Factor, OTK18, The Journal of Immunology, vol.172, issue.1, pp.381-391, 2004.
DOI : 10.4049/jimmunol.172.1.381

M. Horiba, L. Martinez, J. Buescher, S. Sato, J. Limoges et al., OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions, Journal of General Virology, vol.88, issue.1, pp.236-241, 2007.
DOI : 10.1099/vir.0.82066-0

L. Reynolds, C. Ullman, M. Moore, M. Isalan, M. West et al., Repression of the HIV-1 5' LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors, Proceedings of the National Academy of Sciences, vol.100, issue.4, pp.1615-1620, 2003.
DOI : 10.1073/pnas.252770699

K. Carlson, J. Limoges, G. Pohlman, L. Poluektova, D. Langford et al., OTK18 expression in brain mononuclear phagocytes parallels the severity of HIV-1 encephalitis, Journal of Neuroimmunology, vol.150, issue.1-2, pp.186-198, 2004.
DOI : 10.1016/j.jneuroim.2004.01.021

J. Buescher, L. Martinez, S. Sato, S. Okuyama, and T. Ikezu, YY1 and FoxD3 Regulate Antiretroviral Zinc Finger Protein OTK18 Promoter Activation Induced by HIV-1 Infection, Journal of Neuroimmune Pharmacology, vol.79, issue.1, pp.103-115, 2009.
DOI : 10.1007/s11481-008-9139-x

S. Eberhardy, J. Goncalves, S. Coelho, D. Segal, B. Berkhout et al., Inhibition of Human Immunodeficiency Virus Type 1 Replication with Artificial Transcription Factors Targeting the Highly Conserved Primer-Binding Site, Journal of Virology, vol.80, issue.6, pp.2873-2883, 2006.
DOI : 10.1128/JVI.80.6.2873-2883.2006

P. Verschure, A. Visser, and M. Rots, Step out of the Groove: Epigenetic Gene Control Systems and Engineered Transcription Factors, Adv Genet, vol.56, pp.163-204, 2006.
DOI : 10.1016/S0065-2660(06)56005-5

O. Rohr, D. Aunis, and E. Schaeffer, COUP-TF and Sp1 Interact and Cooperate in the Transcriptional Activation of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat in Human Microglial Cells, Journal of Biological Chemistry, vol.272, issue.49, pp.31149-31155, 1997.
DOI : 10.1074/jbc.272.49.31149

R. Oguariri, T. Brann, and T. Imamichi, Hydroxyurea and Interleukin-6 Synergistically Reactivate HIV-1 Replication in a Latently Infected Promonocytic Cell Line via SP1/SP3 Transcription Factors, Journal of Biological Chemistry, vol.282, issue.6, pp.3594-3604, 2007.
DOI : 10.1074/jbc.M608150200

G. Darnell, W. Schroder, J. Gardner, D. Harrich, H. Yu et al., SerpinB2 Is an Inducible Host Factor Involved in Enhancing HIV-1 Transcription and Replication, Journal of Biological Chemistry, vol.281, issue.42, pp.31348-31358, 2006.
DOI : 10.1074/jbc.M604220200

C. Van-lint, Role of chromatin in HIV-1 transcriptional regulation, Adv Pharmacol, vol.48, pp.121-160, 2000.
DOI : 10.1016/S1054-3589(00)48005-1

C. Van-lint, S. Emiliani, M. Ott, and E. Verdin, Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation, Embo J, vol.15, pp.1112-1120, 1996.

E. Verdin, P. Paras, . Jr, and C. Van-lint, Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation, Embo J, vol.12, pp.3249-3259, 1993.

G. Jiang, A. Espeseth, and D. Hazuda, c-Myc and Sp1 Contribute to Proviral Latency by Recruiting Histone Deacetylase 1 to the Human Immunodeficiency Virus Type 1 Promoter, Journal of Virology, vol.81, issue.20, pp.10914-10923, 2007.
DOI : 10.1128/JVI.01208-07

I. Du-chene, E. Basyuk, Y. Lin, R. Triboulet, A. Knezevich et al., Suv39H1 and HP1?? are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency, The EMBO Journal, vol.72, issue.2, pp.424-435, 2007.
DOI : 10.1038/sj.emboj.7601517

URL : https://hal.archives-ouvertes.fr/hal-00130455

P. Correll, A. Morrison, and M. Lutz, Receptor tyrosine kinases and the regulation of macrophage activation, Journal of Leukocyte Biology, vol.75, issue.5, pp.731-737, 2004.
DOI : 10.1189/jlb.0703347

A. Klatt, Z. Zhang, P. Kalantari, P. Hankey, D. Gilmour et al., The Receptor Tyrosine Kinase RON Represses HIV-1 Transcription by Targeting RNA Polymerase II Processivity, The Journal of Immunology, vol.180, issue.3, pp.1670-1677, 2008.
DOI : 10.4049/jimmunol.180.3.1670

E. Lee, P. Kalantari, T. Section, S. Klatt, A. Holden et al., RON Receptor Tyrosine Kinase, a Negative Regulator of Inflammation, Inhibits HIV-1 Transcription in Monocytes/Macrophages and Is Decreased in Brain Tissue from Patients with AIDS, The Journal of Immunology, vol.173, issue.11, pp.6864-6872, 2004.
DOI : 10.4049/jimmunol.173.11.6864

T. Kieffer, M. Finucane, R. Nettles, T. Quinn, K. Broman et al., Genotypic Analysis of HIV???1 Drug Resistance at the Limit of Detection: Virus Production without Evolution in Treated Adults with Undetectable HIV Loads, The Journal of Infectious Diseases, vol.189, issue.8, pp.1452-1465, 2004.
DOI : 10.1086/382488

C. Marban, S. Suzanne, F. Dequiedt, S. De-walque, L. Redel et al., Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing, The EMBO Journal, vol.190, issue.2, pp.412-423, 2007.
DOI : 10.1038/sj.emboj.7601516

D. Avram, A. Fields, K. Pretty-on-top, D. Nevrivy, J. Ishmael et al., Isolation of a Novel Family of C2H2 Zinc Finger Proteins Implicated in Transcriptional Repression Mediated by Chicken Ovalbumin Upstream Promoter Transcription Factor (COUP-TF) Orphan Nuclear Receptors, Journal of Biological Chemistry, vol.275, issue.14, pp.10315-10322, 2000.
DOI : 10.1074/jbc.275.14.10315

M. Leid, J. Ishmael, A. D. Shepherd, D. Fraulob, V. Dolle et al., CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis, Gene Expression Patterns, vol.4, issue.6, pp.1733-739, 2004.
DOI : 10.1016/j.modgep.2004.03.009

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819357

C. Marban, L. Redel, S. S. Van-lint, C. Lecestre, D. Chasserot-golaz et al., COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells, Nucleic Acids Research, vol.33, issue.7, pp.2318-2331, 2005.
DOI : 10.1093/nar/gki529

O. Rohr, D. Lecestre, S. Chasserot-golaz, C. Marban, D. Avram et al., Recruitment of Tat to Heterochromatin Protein HP1 via Interaction with CTIP2 Inhibits Human Immunodeficiency Virus Type 1 Replication in Microglial Cells, Journal of Virology, vol.77, issue.9, pp.5415-5427, 2003.
DOI : 10.1128/JVI.77.9.5415-5427.2003

S. Thierry, V. Marechal, M. Rosenzwajg, M. Sabbah, G. Redeuilh et al., Cell Cycle Arrest in G2 Induces Human Immunodeficiency Virus Type 1 Transcriptional Activation through Histone Acetylation and Recruitment of CBP, NF-??B, and c-Jun to the Long Terminal Repeat Promoter, Journal of Virology, vol.78, issue.22, pp.12198-12206, 2004.
DOI : 10.1128/JVI.78.22.12198-12206.2004

N. Vazquez, T. Greenwell-wild, N. Marinos, W. Swaim, S. Nares et al., Human Immunodeficiency Virus Type 1-Induced Macrophage Gene Expression Includes the p21 Gene, a Target for Viral Regulation, Journal of Virology, vol.79, issue.7, pp.4479-4491, 2005.
DOI : 10.1128/JVI.79.7.4479-4491.2005

T. Cherrier, S. Suzanne, L. Redel, M. Calao, C. Marban et al., (WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1, Oncogene, vol.28, pp.213380-213389, 2009.
DOI : 10.1038/onc.2009.193

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438893

A. Bergamaschi, A. David, L. Rouzic, E. Nisole, S. Barre-sinoussi et al., The CDK Inhibitor p21Cip1/WAF1 Is Induced by Fc??R Activation and Restricts the Replication of Human Immunodeficiency Virus Type 1 and Related Primate Lentiviruses in Human Macrophages, Journal of Virology, vol.83, issue.23, pp.12253-65, 2009.
DOI : 10.1128/JVI.01395-09

P. Brodersen and O. Voinnet, Revisiting the principles of microRNA target recognition and mode of action, Nature Reviews Molecular Cell Biology, vol.125, issue.2, pp.141-148, 2009.
DOI : 10.1038/nrm2619

URL : https://hal.archives-ouvertes.fr/hal-00370008

V. Ambros and X. Chen, The regulation of genes and genomes by small RNAs, Development, vol.134, issue.9, pp.1635-1641, 2007.
DOI : 10.1242/dev.002006

D. Bartel, MicroRNAs, Cell, vol.116, issue.2, pp.281-297, 2004.
DOI : 10.1016/S0092-8674(04)00045-5

URL : https://hal.archives-ouvertes.fr/hal-00369966

M. Yeung, M. Benkirane, and K. Jeang, Small non-coding RNAs, mammalian cells, and viruses: regulatory interactions?, Retrovirology, vol.4, issue.1, p.74, 2007.
DOI : 10.1186/1742-4690-4-74

URL : https://hal.archives-ouvertes.fr/hal-00194073

A. Kumar and K. Jeang, Insights into cellular microRNAs and human immunodeficiency virus type 1 (HIV-1), Journal of Cellular Physiology, vol.4, issue.2, pp.327-331, 2008.
DOI : 10.1002/jcp.21488

R. Triboulet, M. B. Lin, Y. Chable-bessia, C. Bennasser, Y. Lebrigand et al., Suppression of MicroRNA-Silencing Pathway by HIV-1 During Virus Replication, Science, vol.315, issue.5818, pp.1579-1582, 2007.
DOI : 10.1126/science.1136319

URL : https://hal.archives-ouvertes.fr/hal-00138482

J. Huang, F. Wang, E. Argyris, K. Chen, Z. Liang et al., Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes, Nature Medicine, vol.7, issue.10, pp.1241-1247, 2007.
DOI : 10.1038/nm1639

X. Wang, L. Ye, W. Hou, Y. Zhou, Y. Wang et al., Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection, Blood, vol.113, issue.3, pp.671-674, 2009.
DOI : 10.1182/blood-2008-09-175000

T. Sung and A. Rice, miR-198 Inhibits HIV-1 Gene Expression and Replication in Monocytes and Its Mechanism of Action Appears To Involve Repression of Cyclin T1, PLoS Pathogens, vol.70, issue.1, p.1000263, 2009.
DOI : 10.1371/journal.ppat.1000263.g008

Y. Wang and A. Rice, Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis, Virology, vol.352, issue.2, pp.485-492, 2006.
DOI : 10.1016/j.virol.2006.05.013

B. Gekonge, G. Schiralli, R. Schlegel, and A. Henderson, Signal transduction induced by apoptotic cells inhibits HIV transcription in monocytes/macrophages, Journal of Leukocyte Biology, vol.80, issue.4, pp.953-960, 2006.
DOI : 10.1189/jlb.1105638

A. Beg and D. Baltimore, An Essential Role for NF-kappa B in Preventing TNF-alpha -Induced Cell Death, Science, vol.274, issue.5288, pp.782-784, 1996.
DOI : 10.1126/science.274.5288.782

D. Van-antwerp, S. Martin, T. Kafri, D. Green, and I. Verma, Suppression of TNF-alpha -Induced Apoptosis by NF-kappa B, Science, vol.274, issue.5288, pp.787-789, 1996.
DOI : 10.1126/science.274.5288.787

W. Choe, D. Volsky, and M. Potash, Activation of NF-??B by R5 and X4 Human Immunodeficiency Virus Type 1 Induces Macrophage Inflammatory Protein 1?? and Tumor Necrosis Factor Alpha in Macrophages, Journal of Virology, vol.76, issue.10, pp.5274-5277, 2002.
DOI : 10.1128/JVI.76.10.5274-5277.2002

S. Asin, J. Taylor, S. Trushin, G. Bren, and C. Paya, Ikappakappa mediates NFkappaB activation in human immunodeficiency virus-infected cells, J Virol, vol.73, pp.3893-3903, 1999.

J. Mcelhinny, W. Macmorran, G. Bren, R. Ten, A. Israel et al., Regulation of I kappa B alpha and p105 in monocytes and Page, p.16

F. Aillet, H. Masutani, C. Elbim, R. H. Chene, L. Nugeyre et al., Human immunodeficiency virus induces a dual regulation of Bcl-2, resulting in persistent infection of CD4(+) T-or monocytic cell lines, J Virol, vol.72, pp.9698-9705, 1998.

C. Elbim, S. Pillet, M. Prevost, A. Preira, P. Girard et al., Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load, J Virol, vol.73, pp.4561-4566, 1999.

E. Guillemard, C. Jacquemot, F. Aillet, N. Schmitt, F. Barre-sinoussi et al., Human immunodeficiency virus 1 favors the persistence of infection by activating macrophages through TNF, Virology, vol.329, issue.2, pp.371-380, 2004.
DOI : 10.1016/j.virol.2004.08.030

G. Mangino, Z. Percario, G. Fiorucci, G. Vaccari, S. Manrique et al., In Vitro Treatment of Human Monocytes/Macrophages with Myristoylated Recombinant Nef of Human Immunodeficiency Virus Type 1 Leads to the Activation of Mitogen-Activated Protein Kinases, I??B Kinases, and Interferon Regulatory Factor 3 and to the Release of Beta Interferon, Journal of Virology, vol.81, issue.6, pp.2777-2791, 2007.
DOI : 10.1128/JVI.01640-06

A. Varin, S. Manna, V. Quivy, A. Decrion, C. Van-lint et al., Exogenous Nef Protein Activates NF-kappa B, AP-1, and c-Jun N-Terminal Kinase and Stimulates HIV Transcription in Promonocytic Cells. ROLE IN AIDS PATHOGENESIS, Journal of Biological Chemistry, vol.278, issue.4, pp.2219-2227, 2003.
DOI : 10.1074/jbc.M209622200

R. Geleziunas, W. Xu, K. Takeda, H. Ichijo, and W. Greene, HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell, Nature, vol.410, issue.6830, pp.834-838, 2001.
DOI : 10.1038/35071111

E. Olivetta and M. Federico, HIV-1 Nef protects human-monocyte-derived macrophages from HIV-1-induced apoptosis, Experimental Cell Research, vol.312, issue.6, pp.890-900, 2006.
DOI : 10.1016/j.yexcr.2005.12.003

D. Wolf, V. Witte, B. Laffert, K. Blume, E. Stromer et al., HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce antiapoptotic signals, Nature Medicine, vol.7, issue.11, pp.1217-1224, 2001.
DOI : 10.1038/nm1101-1217

A. Greenway, D. Mcphee, A. K. Johnstone, R. Holloway, G. Mills et al., Human Immunodeficiency Virus Type 1 Nef Binds to Tumor Suppressor p53 and Protects Cells against p53-Mediated Apoptosis, Journal of Virology, vol.76, issue.6, pp.2692-2702, 2002.
DOI : 10.1128/JVI.76.6.2692-2702.2002

B. Lee, M. Sharron, L. Montaner, D. Weissman, and R. Doms, Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages, Proceedings of the National Academy of Sciences, vol.96, issue.9, pp.5215-5220, 1999.
DOI : 10.1073/pnas.96.9.5215

J. Lama, A. Mangasarian, and D. Trono, Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner, Current Biology, vol.9, issue.12, pp.622-631, 1999.
DOI : 10.1016/S0960-9822(99)80284-X

M. Collin, P. Illei, W. James, and S. Gordon, Definition of the range and distribution of human immunodeficiency virus macrophage tropism using PCR-based infectivity measurements, Journal of General Virology, vol.75, issue.7, pp.751597-1603, 1994.
DOI : 10.1099/0022-1317-75-7-1597

O. Brien, W. Namazi, A. Kalhor, H. Mao, S. Zack et al., Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors, J Virol, vol.68, pp.1258-1263, 1994.

I. Singh, R. Goody, C. Dean, N. Ahmad, S. Lutz et al., Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G, Journal of Neurovirology, vol.10, issue.3, pp.141-151, 2004.
DOI : 10.1080/13550280490441103

S. Aquaro, P. Bagnarelli, T. Guenci, D. Luca, A. Clementi et al., Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus, Journal of Medical Virology, vol.106, issue.4, pp.479-488, 2002.
DOI : 10.1002/jmv.10245

P. Chugh, S. Fan, V. Planelles, S. Maggirwar, S. Dewhurst et al., Infection of Human Immunodeficiency Virus and Intracellular Viral Tat Protein Exert a Pro-survival Effect in a Human Microglial Cell Line, Journal of Molecular Biology, vol.366, issue.1, pp.67-81, 2007.
DOI : 10.1016/j.jmb.2006.11.011

O. Lambotte, K. Deiva, and M. Tardieu, HIV-1 Persistence, Viral Reservoir, and the Central Nervous System in the HAART Era, Brain Pathology, vol.340, issue.1, pp.95-103, 2003.
DOI : 10.1111/j.1750-3639.2003.tb00010.x

L. Zheng, Y. Yang, L. Guocai, C. Pauza, and M. Salvato, HIV Tat Protein Increases Bcl-2 Expression in Monocytes Which Inhibits Monocyte Apoptosis Induced by Tumor Necrosis Factor-Alpha-Related Apoptosis-Induced Ligand, Intervirology, vol.50, issue.3, pp.224-228, 2007.
DOI : 10.1159/000100565

K. Kamimura, Y. Mishima, M. Obata, T. Endo, Y. Aoyagi et al., Lack of Bcl11b tumor suppressor results in vulnerability to DNA replication stress and damages, Oncogene, vol.300, issue.40, pp.5840-50, 2007.
DOI : 10.1038/sj.onc.1210388

C. Patel, M. Mukhtar, S. Harley, J. Kulkosky, and R. Pomerantz, Lentiviral expression of HIV-1 Vpr induces apoptosis in human neurons, Journal of Neurovirology, vol.8, issue.2, pp.86-99, 2002.
DOI : 10.1080/13550280290049552

M. Somasundaran, M. Sharkey, B. Brichacek, K. Luzuriaga, M. Emerman et al., Evidence for a cytopathogenicity determinant in HIV-1 Vpr, Proceedings of the National Academy of Sciences, vol.99, issue.14, pp.9503-9508, 2002.
DOI : 10.1073/pnas.142313699

S. Stewart, B. Poon, J. Song, and I. Chen, Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis through Caspase Activation, Journal of Virology, vol.74, issue.7, pp.3105-3111, 2000.
DOI : 10.1128/JVI.74.7.3105-3111.2000

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC111809/pdf

M. Giri, M. Nebozyhn, R. A. Gekonge, B. Hancock, A. Creer et al., Circulating Monocytes in HIV-1-Infected Viremic Subjects Exhibit an Antiapoptosis Gene Signature and Virus- and Host-Mediated Apoptosis Resistance, The Journal of Immunology, vol.182, issue.7, pp.4459-4470, 2009.
DOI : 10.4049/jimmunol.0801450

A. Gartel, Is p21 an oncogene? Mol Cancer Ther, pp.1385-1386, 2006.
DOI : 10.1158/1535-7163.mct-06-0163

A. Gartel, WAF1/CIP1) May Be a Tumor Suppressor After All, Cancer Biol Ther, p.216, 2007.

S. Swingler, A. Mann, J. Zhou, C. Swingler, and M. Stevenson, Apoptotic Killing of HIV-1???Infected Macrophages Is Subverted by the Viral Envelope Glycoprotein, PLoS Pathogens, vol.167, issue.9, pp.1281-1290, 2007.
DOI : 10.1371/journal.ppat.0030134.sg004

G. Hutter, D. Nowak, M. Mossner, S. Ganepola, A. Mussig et al., Delta32/Delta32 Stem-Cell Transplantation, New England Journal of Medicine, vol.360, issue.7, pp.692-698, 2009.
DOI : 10.1056/NEJMoa0802905

Y. Bennasser, M. Yeung, and K. Jeang, HIV-1 TAR RNA Subverts RNA Interference in Transfected Cells through Sequestration of TAR RNA-binding Protein, TRBP, Journal of Biological Chemistry, vol.281, issue.38, pp.27674-27678, 2006.
DOI : 10.1074/jbc.C600072200

Z. Klase, R. Winograd, J. Davis, L. Carpio, R. Hildreth et al., HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression, Retrovirology, vol.6, issue.1, p.18, 2009.
DOI : 10.1186/1742-4690-6-18

B. Mcgee, N. Smith, and F. Aweeka, HIV Pharmacology: Barriers to the Eradication of HIV from the CNS, HIV Clinical Trials, vol.11, issue.7, pp.142-153, 2006.
DOI : 10.1097/00002030-200004140-00005

R. Sawchuk and Z. Yang, Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system, Advanced Drug Delivery Reviews, vol.39, issue.1-3, pp.5-31, 1999.
DOI : 10.1016/S0169-409X(99)00017-4

C. Solas, A. Lafeuillade, P. Halfon, S. Chadapaud, G. Hittinger et al., Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients, Antimicrobial Agents and Chemotherapy, vol.47, issue.1, pp.238-243, 2003.
DOI : 10.1128/AAC.47.1.238-243.2003

C. Perno, F. Newcomb, D. Davis, S. Aquaro, R. Humphrey et al., Relative Potency of Protease Inhibitors in Monocytes/Macrophages Acutely and Chronically Infected with Human Immunodeficiency Virus, Journal of Infectious Diseases, vol.178, issue.2, pp.413-422, 1998.
DOI : 10.1086/515642

M. Hermankova, S. Ray, C. Ruff, M. Powell-davis, R. Ingersoll et al., HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination Therapy, JAMA, vol.286, issue.2, pp.196-207, 2001.
DOI : 10.1001/jama.286.2.196

R. Nettles, T. Kieffer, P. Kwon, D. Monie, Y. Han et al., Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAART, JAMA, vol.293, issue.7, pp.817-829, 2005.
DOI : 10.1001/jama.293.7.817

M. Baba, Recent status of HIV-1 gene expression inhibitors, Antiviral Research, vol.71, issue.2-3, pp.301-306, 2006.
DOI : 10.1016/j.antiviral.2006.01.002

A. Gatignol and K. Jeang, Tat as a transcriptional activator and a potential therapeutic target for HIV-I, Adv Pharmacol, vol.48, pp.209-227, 2000.
DOI : 10.1016/S1054-3589(00)48007-5

M. Stevens, D. Clercq, E. Balzarini, and J. , The regulation of HIV-1 transcription: Molecular targets for chemotherapeutic intervention, Medicinal Research Reviews, vol.79, issue.5, pp.595-625, 2006.
DOI : 10.1002/med.20081

S. Aquaro, V. Svicher, D. Schols, M. Pollicita, A. Antinori et al., Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies, Journal of Leukocyte Biology, vol.80, issue.5, pp.1103-1110, 2006.
DOI : 10.1189/jlb.0606376

A. Bouazzaoui, M. Kreutz, V. Eisert, N. Dinauer, A. Heinzelmann et al., Stimulated trans-acting factor of 50??kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages, Virology, vol.356, issue.1-2, pp.79-94, 2006.
DOI : 10.1016/j.virol.2006.07.025

A. Crotti, M. Lusic, R. Lupo, P. Lievens, E. Liboi et al., Naturally occurring C-terminally truncated STAT5 is a negative regulator of HIV-1 expression, Blood, vol.109, issue.12, pp.5380-5389, 2007.
DOI : 10.1182/blood-2006-08-042556

P. Kalantari, V. Narayan, S. Natarajan, K. Muralidhar, U. Gandhi et al., Thioredoxin Reductase-1 Negatively Regulates HIV-1 Transactivating Protein Tat-dependent Transcription in Human Macrophages, Journal of Biological Chemistry, vol.283, issue.48, pp.33183-33190, 2008.
DOI : 10.1074/jbc.M807403200

A. Mosoian, A. Teixeira, A. High, R. Christian, D. Hunt et al., Novel Function of Prothymosin Alpha as a Potent Inhibitor of Human Immunodeficiency Virus Type 1 Gene Expression in Primary Macrophages, Journal of Virology, vol.80, issue.18, pp.9200-9206, 2006.
DOI : 10.1128/JVI.00589-06

S. Ranjbar, A. Tsytsykova, S. Lee, R. Rajsbaum, J. Falvo et al., NFAT5 Regulates HIV-1 in Primary Monocytes via a Highly Conserved Long Terminal Repeat Site, PLoS Pathogens, vol.9, issue.12, p.130, 2006.
DOI : 10.1371/journal.ppat.0020130.sg001

N. Tanaka, Y. Hoshino, J. Gold, S. Hoshino, F. Martiniuk et al., Interleukin-10 Induces Inhibitory C/EBP?? through STAT-3 and Represses HIV-1 Transcription in Macrophages, American Journal of Respiratory Cell and Molecular Biology, vol.33, issue.4, pp.406-411, 2005.
DOI : 10.1165/rcmb.2005-0140OC

R. Jochmann, M. Thurau, S. Jung, C. Hofmann, E. Naschberger et al., O-Linked N-Acetylglucosaminylation of Sp1 Inhibits the Human Immunodeficiency Virus Type 1 Promoter, Journal of Virology, vol.83, issue.8, pp.3704-3718, 2009.
DOI : 10.1128/JVI.01384-08

J. Buescher, F. Duan, J. Sun, R. Price, and T. Ikezu, OTK18 Levels in Plasma and Cerebrospinal Fluid Correlate with Viral Load and CD8 T-cells in Normal and AIDS Patients, Journal of Neuroimmune Pharmacology, vol.4, issue.Suppl 1, pp.230-235, 2008.
DOI : 10.1007/s11481-008-9125-3

J. Prins, S. Jurriaans, R. Van-praag, H. Blaak, R. Van-rij et al., Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy, AIDS, vol.13, issue.17, pp.2405-2410, 1999.
DOI : 10.1097/00002030-199912030-00012

H. Yang, L. Shen, R. Siliciano, and J. Pomerantz, Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation, Proceedings of the National Academy of Sciences, vol.106, issue.15, pp.6321-6326, 2009.
DOI : 10.1073/pnas.0809536106

S. Reuse, M. Calao, K. Kabeya, A. Guiguen, J. Gatot et al., Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection, PLoS ONE, vol.4, issue.6, p.6093, 2009.
DOI : 10.1371/journal.pone.0006093.s008

URL : https://hal.archives-ouvertes.fr/hal-00464770

S. Kauder, A. Bosque, A. Lindqvist, V. Planelles, and E. Verdin, Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation, PLoS Pathogens, vol.20, issue.6, p.1000495, 2009.
DOI : 10.1371/journal.ppat.1000495.s009

M. Saag, J. Goodrich, G. Fatkenheuer, B. Clotet, N. Clumeck et al., A Double???Blind, Placebo???Controlled Trial of Maraviroc in Treatment???Experienced Patients Infected with Non???R5 HIV???1, The Journal of Infectious Diseases, vol.199, issue.11, pp.1638-1647, 2009.
DOI : 10.1086/598965

D. Kuritzkes, HIV-1 entry inhibitors: an overview, Current Opinion in HIV and AIDS, vol.4, issue.2, pp.82-87, 2009.
DOI : 10.1097/COH.0b013e328322402e

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753507

P. Chugh, B. Bradel-tretheway, C. Monteiro-filho, V. Planelles, S. Maggirwar et al., Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy, Retrovirology, vol.5, issue.1, p.11, 2008.
DOI : 10.1186/1742-4690-5-11

URL : http://doi.org/10.1186/1742-4690-5-11